GeneDx Holdings Corp (WGS)
GeneDx Holdings Corp. is a healthcare company focused on genomics and genetic testing services. Through its common stock listed on the NASDAQ exchange under the symbol WGS, investors gain exposure to a business centered on pediatric and rare disease diagnostics, including whole exome and genome sequencing. The company also provides data and information services and has developed an AI-based platform used for next generation sequencing analysis, interpretation, and clinical reporting across rare disease, hereditary risk, and cancer testing. GeneDx was founded in 2000 and is headquartered in Stamford, Connecticut.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-WGS
|
$55.90
|
-8.0% Downside
|
Fair
|
$81.78
|
34.5% Upside
|
Undervalued
|
Good
|
—
|
—
|
—
|
0.0%
|
August 3, 2026
|
-23.2x
|
7.1x
|
4.1x
|
1.801 B
|
1.806 B
|
8.5%
|
63.8%
|
0.2
|
—
|
36.8%
|
